A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
05 Oct 2022
Historique:
received: 17 05 2022
revised: 22 06 2022
accepted: 23 06 2022
pubmed: 3 7 2022
medline: 17 8 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

As an essential enzyme of SARS-CoV-2, the COVID-19 pathogen, main protease (M

Identifiants

pubmed: 35779291
pii: S0223-5234(22)00472-X
doi: 10.1016/j.ejmech.2022.114570
pmc: PMC9235293
pii:
doi:

Substances chimiques

Aldehydes 0
Antiviral Agents 0
Protease Inhibitors 0
Threonine 2ZD004190S
Coronavirus 3C Proteases EC 3.4.22.28

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114570

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM124169
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI164088
Pays : United States
Organisme : NIBIB NIH HHS
ID : R21 EB032983
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Références

Science. 2021 Mar 26;371(6536):1374-1378
pubmed: 33602867
ACS Cent Sci. 2021 Mar 24;7(3):467-475
pubmed: 33786375
Viruses. 2021 Jan 25;13(2):
pubmed: 33503819
J Virol. 2021 Jun 24;95(14):e0237420
pubmed: 33910954
Cell Chem Biol. 2021 Dec 16;28(12):1795-1806.e5
pubmed: 34174194
ACS Cent Sci. 2022 Feb 23;8(2):192-204
pubmed: 35229034
Cold Spring Harb Protoc. 2018 Jun 1;2018(6):
pubmed: 29858338
Signal Transduct Target Ther. 2021 Mar 27;6(1):134
pubmed: 33774649
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Nat Struct Mol Biol. 2020 Jun;27(6):529-532
pubmed: 32382072
ACS Med Chem Lett. 2020 Oct 25;11(12):2526-2533
pubmed: 33324471
Science. 2020 Jun 19;368(6497):1331-1335
pubmed: 32321856
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nat Commun. 2020 Sep 4;11(1):4417
pubmed: 32887884
J Med Chem. 2020 Nov 12;63(21):12725-12747
pubmed: 33054210
Cell Rep. 2020 Oct 13;33(2):108254
pubmed: 33007239
Cell Res. 2020 Aug;30(8):678-692
pubmed: 32541865
Cell. 2020 May 14;181(4):914-921.e10
pubmed: 32330414
J Med Chem. 2022 Jul 14;65(13):8686-8698
pubmed: 35731933
Science. 2021 Dec 24;374(6575):1586-1593
pubmed: 34726479
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33597253
ACS Pharmacol Transl Sci. 2020 Sep 04;3(5):1008-1016
pubmed: 33062953
Chembiochem. 2020 Mar 2;21(5):730-738
pubmed: 32022370
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33526482
Nat Commun. 2021 Apr 1;12(1):2016
pubmed: 33795671
Nat Commun. 2021 Jan 28;12(1):668
pubmed: 33510133
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
J Am Chem Soc. 2021 Dec 15;143(49):20697-20709
pubmed: 34860011
J Med Chem. 2022 Feb 24;65(4):2794-2808
pubmed: 33872498
ChemMedChem. 2022 Jan 5;17(1):e202100456
pubmed: 34242492
Science. 2021 May 7;372(6542):642-646
pubmed: 33811162
Sci Adv. 2020 Dec 9;6(50):
pubmed: 33158912
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
ChemMedChem. 2021 Mar 18;16(6):942-948
pubmed: 33283984
Nat Commun. 2020 Oct 7;11(1):5047
pubmed: 33028810
Sci Transl Med. 2020 Aug 19;12(557):
pubmed: 32747425
ACS Pharmacol Transl Sci. 2020 Oct 09;3(6):1265-1277
pubmed: 33330841

Auteurs

Yuying Ma (Y)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Kai S Yang (KS)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Zhi Zachary Geng (ZZ)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Yugendar R Alugubelli (YR)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Namir Shaabani (N)

Sorrento Therapeutics, Inc. San Diego, CA, 92121, USA.

Erol C Vatansever (EC)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Xinyu R Ma (XR)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Chia-Chuan Cho (CC)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Kaustav Khatua (K)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Jing Xiao (J)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Lauren R Blankenship (LR)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Ge Yu (G)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA.

Banumathi Sankaran (B)

Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Laurence Berkeley National Laboratory, Berkeley, CA, 94720, USA.

Pingwei Li (P)

Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.

Robert Allen (R)

Sorrento Therapeutics, Inc. San Diego, CA, 92121, USA.

Henry Ji (H)

Sorrento Therapeutics, Inc. San Diego, CA, 92121, USA. Electronic address: hji@sorrentotherapeutics.com.

Shiqing Xu (S)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA. Electronic address: shiqing.xu@tamu.edu.

Wenshe Ray Liu (WR)

Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA; Institute of Biosciences and Technology and Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX, 77030, USA; Department of Molecular and Cellular Medicine, College of Medicine, Texas A&M University, College Station, TX, 77843, USA. Electronic address: wsliu2007@tamu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH